EFTRW
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
EFTRW
Delisted
EFTRW was delisted on the 2nd of July, 2024.
17 hedge funds and large institutions have $2.94M invested in eFFECTOR Therapeutics, Inc. Warrant in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
-4
Holders Change %
-19.05%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
7
Closed
7
Calls
$484K
Puts
–
Net Calls
+$484K
Net Calls Change
-$253K
Top Buyers
Top Sellers
1 |
HCM
Highbridge Capital Management
New York
|
-$517K |
2 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$213K |
3 |
Blackstone Inc
New York
|
-$163K |
4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$91.2K |
5 |
AGM
Alpine Global Management
New York
|
-$65K |